Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-25

Clinical Trial Update: Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers [Phase 4]

View source ↗

Summary

Clinical trial update reporting Phase 4 results for platelet-rich plasma as a treatment for resistant corneal ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Alaa Gamal | Conditions: Cornea Ulcer | Phase 4 | Status: COMPLETED